Skip to main content
Top
Published in: Inflammation 4/2012

01-08-2012

Alteration of Some Inflammatory Biomarkers by Dietary Oxysterols in Rats

Authors: Ida Soto-Rodríguez, Alfonso Alexander-Aguilera, Antonio Zamudio-Pérez, Mireya Camara-Contreras, Guillermo Hernandez-Diaz, Hugo S. Garcia

Published in: Inflammation | Issue 4/2012

Login to get access

Abstract

Oxysterols are structurally similar to cholesterol, but are characterized by one or more additional oxygen-containing functional groups. These compounds are implicated in inflammation given their ability to cause irreversible damage to vascular cells. The aim of this study was to study the alteration of some inflammatory biomarkers in Wistar rats in response to dietary oxysterols. Eighteen rats were randomly divided into three groups of six rats each. A standard diet supplemented with 1% (w/w) pure cholesterol (Chol group) or 1% (w/w) of an oxidized cholesterol mixture (COPs group) was fed for 8 weeks. Blood serum was separated; abdominal, pericardial, and epididymal adipose tissue was removed carefully. The COPs subjects exhibited significant increase in blood pressure and serum triacylgycerols as well as increased body fat index and pericardic, abdominal, and epididymal adipose tissue. These effects were accompanied by elevated circulating levels of plasma high-sensitivity C-reactive protein, tumor necrosis factor alpha, and resistin. We suggest that dietary oxysterols have an important pro-inflammatory effect.
Literature
1.
go back to reference Schroepfer, G.J. 2000. Oxysterols: Modulators of cholesterol metabolism and other processes. Physiological Reviews 80: 361–554.PubMed Schroepfer, G.J. 2000. Oxysterols: Modulators of cholesterol metabolism and other processes. Physiological Reviews 80: 361–554.PubMed
2.
go back to reference Vejux, A., L. Malvitte, and G. Lizard. 2008. Side effects of oxysterols: Cytotoxicity, oxidation, inflammation, and phospholipidosis. Brazilian Journal of Medical and Biological Research 41: 545–556.PubMedCrossRef Vejux, A., L. Malvitte, and G. Lizard. 2008. Side effects of oxysterols: Cytotoxicity, oxidation, inflammation, and phospholipidosis. Brazilian Journal of Medical and Biological Research 41: 545–556.PubMedCrossRef
3.
go back to reference Lemaire-Ewing, S., C. Prunet, T. Montange, A. Vejux, A. Berthier, G. Bessède, L. Corcos, P. Gambert, D. Néel, and G. Lizard. 2005. Comparison of the cytotoxic, pro-oxidant and proinflammatory characteristics of different oxysterols. Cell Biology and Toxicology 21: 97–114.PubMedCrossRef Lemaire-Ewing, S., C. Prunet, T. Montange, A. Vejux, A. Berthier, G. Bessède, L. Corcos, P. Gambert, D. Néel, and G. Lizard. 2005. Comparison of the cytotoxic, pro-oxidant and proinflammatory characteristics of different oxysterols. Cell Biology and Toxicology 21: 97–114.PubMedCrossRef
4.
go back to reference Vejux, A., S. Guyot, T. Montange, J.M. Riedinger, E. Kahn, and G. Lizard. 2009. Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signaling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. The Journal of Nutritional Biochemistry 20: 45–61.PubMedCrossRef Vejux, A., S. Guyot, T. Montange, J.M. Riedinger, E. Kahn, and G. Lizard. 2009. Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signaling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. The Journal of Nutritional Biochemistry 20: 45–61.PubMedCrossRef
5.
go back to reference Libby, P. 2007. Inflammatory mechanisms: The molecular basis of inflammation and disease. Nutrition Reviews 65: S140–S146.PubMedCrossRef Libby, P. 2007. Inflammatory mechanisms: The molecular basis of inflammation and disease. Nutrition Reviews 65: S140–S146.PubMedCrossRef
6.
go back to reference Poli, G., B. Sottero, S. Gargiulo, and G. Leonarduzzi. 2009. Cholesterol oxidation products in the vascular remodeling due to atherosclerosis. Molecular Aspects of Medicine 30: 180–189.PubMedCrossRef Poli, G., B. Sottero, S. Gargiulo, and G. Leonarduzzi. 2009. Cholesterol oxidation products in the vascular remodeling due to atherosclerosis. Molecular Aspects of Medicine 30: 180–189.PubMedCrossRef
7.
go back to reference Pachard, R.R.S., and P. Libby. 2008. Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction. Clinical Chemistry 54: 24–38.CrossRef Pachard, R.R.S., and P. Libby. 2008. Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction. Clinical Chemistry 54: 24–38.CrossRef
8.
go back to reference Steppan, C.M., S.T. Bailey, S. Bhat, and E.J. Brown. 2001. The hormone resistin links obesity to diabetes. Nature 409: 307–312.PubMedCrossRef Steppan, C.M., S.T. Bailey, S. Bhat, and E.J. Brown. 2001. The hormone resistin links obesity to diabetes. Nature 409: 307–312.PubMedCrossRef
9.
go back to reference Fargnoli, J.L., Q. Sun, D. Olenczuk, L. Qi, Y. Zhu, F.B. Hu, and C.S. Mantzoros. 2010. Resistin is associated with biomarkers of inflammation while total and HMW adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. European Journal of Endocrinology 162: 281–288.PubMedCrossRef Fargnoli, J.L., Q. Sun, D. Olenczuk, L. Qi, Y. Zhu, F.B. Hu, and C.S. Mantzoros. 2010. Resistin is associated with biomarkers of inflammation while total and HMW adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. European Journal of Endocrinology 162: 281–288.PubMedCrossRef
10.
go back to reference Ridker, P.M. 2003. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363–369.PubMedCrossRef Ridker, P.M. 2003. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107: 363–369.PubMedCrossRef
11.
go back to reference Momiyama, Y., R. Ohmori, H. Uto-Kondo, N. Tanaka, R. Kato, H. Taniguchi, K. Arakawa, H. Nakamura, and F. Ohsuzu. 2011. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention. Journal of Atherosclerosis and Thrombosis 18: 108–114.PubMedCrossRef Momiyama, Y., R. Ohmori, H. Uto-Kondo, N. Tanaka, R. Kato, H. Taniguchi, K. Arakawa, H. Nakamura, and F. Ohsuzu. 2011. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention. Journal of Atherosclerosis and Thrombosis 18: 108–114.PubMedCrossRef
12.
go back to reference Reilly, M.P., M. Lehrke, M.L. Wolfe, A. Rohatgi, M.A. Lazar, and D.J. Rader. 2005. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932–939.PubMedCrossRef Reilly, M.P., M. Lehrke, M.L. Wolfe, A. Rohatgi, M.A. Lazar, and D.J. Rader. 2005. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111: 932–939.PubMedCrossRef
13.
go back to reference Sweeley, C.C., R. Bentley, M. Makita, and W.W. Wells. 1963. Gas liquid chromatography of trimethylsilyl derivates of sugars and related substances. Journal of the American Chemical Society 85: 2497–2506.CrossRef Sweeley, C.C., R. Bentley, M. Makita, and W.W. Wells. 1963. Gas liquid chromatography of trimethylsilyl derivates of sugars and related substances. Journal of the American Chemical Society 85: 2497–2506.CrossRef
14.
go back to reference SAGDPA. 1999. Especificaciones técnicas para la producción, cuidado y uso de los animales de laboratorio. Secretaría de Agricultura, Ganadería, Desarrollo Rural, Pesca y Alimentación: México. Norma Oficial Mexicana: NOM-062-ZOO-1999. SAGDPA. 1999. Especificaciones técnicas para la producción, cuidado y uso de los animales de laboratorio. Secretaría de Agricultura, Ganadería, Desarrollo Rural, Pesca y Alimentación: México. Norma Oficial Mexicana: NOM-062-ZOO-1999.
15.
go back to reference Al Kanhal, M.A., F. Ahmad, A.A. Al Othman, Z. Arif, S. Al Orf, and K.S. Al Murshed. 2002. Effect of pure oxidized cholesterol-rich diets on some biochemical parameters in rats. International Journal of Food Science and Nutrition 53: 381–388.CrossRef Al Kanhal, M.A., F. Ahmad, A.A. Al Othman, Z. Arif, S. Al Orf, and K.S. Al Murshed. 2002. Effect of pure oxidized cholesterol-rich diets on some biochemical parameters in rats. International Journal of Food Science and Nutrition 53: 381–388.CrossRef
16.
go back to reference Barham, D., and P. Trinder. 1972. An improved color reagent for the determination of blood glucose by the oxidase system. Analyst 97: 142–145.PubMedCrossRef Barham, D., and P. Trinder. 1972. An improved color reagent for the determination of blood glucose by the oxidase system. Analyst 97: 142–145.PubMedCrossRef
17.
go back to reference Assmann, G. 1979. Lipid determinations today. Internist 20: 559–564.PubMed Assmann, G. 1979. Lipid determinations today. Internist 20: 559–564.PubMed
18.
go back to reference Rifai, N., R.P. Tracy, and P.M. Ridker. 1999. Clinical efficacy of an automated high sensitivity C-reactive protein assay. Clinical Chemistry 45: 2136–2141.PubMed Rifai, N., R.P. Tracy, and P.M. Ridker. 1999. Clinical efficacy of an automated high sensitivity C-reactive protein assay. Clinical Chemistry 45: 2136–2141.PubMed
19.
go back to reference Ridker, P.M. 2001. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103: 1813–1818.PubMedCrossRef Ridker, P.M. 2001. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103: 1813–1818.PubMedCrossRef
20.
go back to reference Wieland, H., and D. Seidel. 1983. A simple method for precipitation of low density lipoprotein. Journal of Lipid Research 24: 904–909.PubMed Wieland, H., and D. Seidel. 1983. A simple method for precipitation of low density lipoprotein. Journal of Lipid Research 24: 904–909.PubMed
21.
go back to reference Finley, P.R., R.B. Schifman, R.J. Williams, and D.A. Lichti. 1978. Cholesterol on high density lipoprotein: Use of Mg2+/dextran sulfate in its enzymatic measurement. Clinical Chemistry 24: 931–933.PubMed Finley, P.R., R.B. Schifman, R.J. Williams, and D.A. Lichti. 1978. Cholesterol on high density lipoprotein: Use of Mg2+/dextran sulfate in its enzymatic measurement. Clinical Chemistry 24: 931–933.PubMed
22.
go back to reference Yang, J.Y.O., Y. Park, H.R. Zhang, X.B. Yu, G.A. Laine, K.C. Dellsperger, and C.H. Zhang. 2009. Feed-forward signaling of TNF-alpha and NF kappa B via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice. American Journal of Physiology-Heart and Circulatory Physiology 296: H1850–H1858.PubMedCrossRef Yang, J.Y.O., Y. Park, H.R. Zhang, X.B. Yu, G.A. Laine, K.C. Dellsperger, and C.H. Zhang. 2009. Feed-forward signaling of TNF-alpha and NF kappa B via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice. American Journal of Physiology-Heart and Circulatory Physiology 296: H1850–H1858.PubMedCrossRef
23.
go back to reference Staprans, I., X.M. Pan, J.H. Rapp, and K.R. Feingold. 2005. The role of dietary oxidized cholesterol and fatty acids in the development of atherosclerosis. Molecular Nutrition & Food Research 49: 1075–1082.CrossRef Staprans, I., X.M. Pan, J.H. Rapp, and K.R. Feingold. 2005. The role of dietary oxidized cholesterol and fatty acids in the development of atherosclerosis. Molecular Nutrition & Food Research 49: 1075–1082.CrossRef
24.
go back to reference Soto-Rodriguez, I., P.J. Campillo-Velazquez, A. Alexander-Aguilera, M.T. Rodriguez-Estrada, G. Lercker, and H.S. García. 2009. Biochemical and histopathological effects of dietary oxidized cholesterol in rats. Journal of Applied Toxicology 29: 715–723.PubMedCrossRef Soto-Rodriguez, I., P.J. Campillo-Velazquez, A. Alexander-Aguilera, M.T. Rodriguez-Estrada, G. Lercker, and H.S. García. 2009. Biochemical and histopathological effects of dietary oxidized cholesterol in rats. Journal of Applied Toxicology 29: 715–723.PubMedCrossRef
25.
26.
go back to reference Repa, J.J., G.S. Liang, J.F. Ou, Y. Bashmakov, J.M.A. Lobaccaro, I. Shimomura, B. Shan, M.S. Brown, J.L. Goldstein, and D.J. Mangelsdorf. 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes & Development 14: 2819–2830.CrossRef Repa, J.J., G.S. Liang, J.F. Ou, Y. Bashmakov, J.M.A. Lobaccaro, I. Shimomura, B. Shan, M.S. Brown, J.L. Goldstein, and D.J. Mangelsdorf. 2000. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes & Development 14: 2819–2830.CrossRef
27.
go back to reference DeBose-Boyd, R.A., J. Ou, J.L. Goldstein, and M.S. Brown. 2001. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Proceedings of the National Academy of Sciences of the United States of America 98: 1477–1482.PubMedCrossRef DeBose-Boyd, R.A., J. Ou, J.L. Goldstein, and M.S. Brown. 2001. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Proceedings of the National Academy of Sciences of the United States of America 98: 1477–1482.PubMedCrossRef
28.
go back to reference Wamil, M., R. Andrew, K. Chapman, J. Street, N. Morton, and J.R. Seckl. 2008. 7-Oxysterols modulate glucocorticoid activity in adipocytes through competition for 11β-hydroxysteroid dehydrogenase type. Endocrinology 149: 5909–5918.PubMedCrossRef Wamil, M., R. Andrew, K. Chapman, J. Street, N. Morton, and J.R. Seckl. 2008. 7-Oxysterols modulate glucocorticoid activity in adipocytes through competition for 11β-hydroxysteroid dehydrogenase type. Endocrinology 149: 5909–5918.PubMedCrossRef
29.
go back to reference Leonarduzzi, G., B. Sottero, and G. Poli. 2002. Oxidized products of cholesterol: Dietary and metabolic origin, and proatherosclerotic effects (review). The Journal of Nutritional Biochemistry 13: 700–710.PubMedCrossRef Leonarduzzi, G., B. Sottero, and G. Poli. 2002. Oxidized products of cholesterol: Dietary and metabolic origin, and proatherosclerotic effects (review). The Journal of Nutritional Biochemistry 13: 700–710.PubMedCrossRef
30.
go back to reference Prunet, C., T. Montange, A. Véjux, A. Laubriet, J.F. Rohmer, J.M. Riedinger, A. Athias, S. Lemaire-Ewing, D. Néel, J.M. Petit, E. Steinmetz, R. Brenot, P. Gambert, and G. Lizard. 2006. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry. Part A 69A: 359–373.CrossRef Prunet, C., T. Montange, A. Véjux, A. Laubriet, J.F. Rohmer, J.M. Riedinger, A. Athias, S. Lemaire-Ewing, D. Néel, J.M. Petit, E. Steinmetz, R. Brenot, P. Gambert, and G. Lizard. 2006. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry. Part A 69A: 359–373.CrossRef
31.
go back to reference Sottero, B., P. Gamba, S. Gargiulo, G. Leonarduzzi, and G. Poli. 2009. Cholesterol oxidation products and disease: An emerging topic of interest in medical chemistry. Current Medicinal Chemistry 16: 685–705.PubMedCrossRef Sottero, B., P. Gamba, S. Gargiulo, G. Leonarduzzi, and G. Poli. 2009. Cholesterol oxidation products and disease: An emerging topic of interest in medical chemistry. Current Medicinal Chemistry 16: 685–705.PubMedCrossRef
32.
go back to reference Li, Y., Y. Wang, Q. Li, Y. Chen, S.Z. Sun, W.D. Zhang, and Q. Jia. 2007. Effect of resistin on vascular endothelium secretion dysfunction in rats. Endothelium 14: 207–214.PubMed Li, Y., Y. Wang, Q. Li, Y. Chen, S.Z. Sun, W.D. Zhang, and Q. Jia. 2007. Effect of resistin on vascular endothelium secretion dysfunction in rats. Endothelium 14: 207–214.PubMed
33.
go back to reference De Luis, D.A., M. González-Sagrado, R. Conde, R. Aller, and O. Izaola. 2010. Resistin levels and inflammatory markers in patients with morbid obesity. Nutricion Hospitalaria 25: 630–634.PubMed De Luis, D.A., M. González-Sagrado, R. Conde, R. Aller, and O. Izaola. 2010. Resistin levels and inflammatory markers in patients with morbid obesity. Nutricion Hospitalaria 25: 630–634.PubMed
34.
go back to reference Bokarewa, M., I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski. 2005. Resistin, an adipokine with potent proinflammatory properties. Journal of Immunology 174: 5789–5795. Bokarewa, M., I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski. 2005. Resistin, an adipokine with potent proinflammatory properties. Journal of Immunology 174: 5789–5795.
35.
go back to reference Wilson, P.W.F., M. Pencina, P. Jacques, J. Selhub, R. D'Agostino, and C.J. O'Donnell. 2008. C-Reactive protein and reclassification of cardiovascular risk in the Framingham heart study. Circulation. Cardiovascular Quality and Outcomes 1: 92–97.PubMedCrossRef Wilson, P.W.F., M. Pencina, P. Jacques, J. Selhub, R. D'Agostino, and C.J. O'Donnell. 2008. C-Reactive protein and reclassification of cardiovascular risk in the Framingham heart study. Circulation. Cardiovascular Quality and Outcomes 1: 92–97.PubMedCrossRef
36.
go back to reference Al-Daghri, N., R. Chetty, P.G. McTernan, K. Al-Rubean, O. Al-Attas, A.F. Jones, and S. Kumar. 2005. Serum resistin is associated with C-reactive protein and LDL-cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovascular Diabetology 4: 10. doi:10.1186/1475-2840-4-10.PubMedCrossRef Al-Daghri, N., R. Chetty, P.G. McTernan, K. Al-Rubean, O. Al-Attas, A.F. Jones, and S. Kumar. 2005. Serum resistin is associated with C-reactive protein and LDL-cholesterol in type 2 diabetes and coronary artery disease in a Saudi population. Cardiovascular Diabetology 4: 10. doi:10.​1186/​1475-2840-4-10.PubMedCrossRef
37.
go back to reference Brown, A., and W. Jessup. 2009. Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Molecular Aspects of Medicine 30: 111–122.PubMedCrossRef Brown, A., and W. Jessup. 2009. Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Molecular Aspects of Medicine 30: 111–122.PubMedCrossRef
38.
go back to reference Johnson, J.S., V. Meliton, K.W. Kyun, K.L. Bok, C.J. Wang, K.L. Nguyen, D. Yoo, E.M. Jung, E. Atti, S. Tetradis, C.R. Pereira, C. Magyar, T. Nargizyan, J.T. Hahn, F. Farouz, S. Thies, and F. Parhami. 2011. Novel oxysterols have pro-osteogenic and anti-adipogenic effects in vitro and induce spinal fusion in vivo. Journal of Cell Biochemistry 112: 1673–1684.CrossRef Johnson, J.S., V. Meliton, K.W. Kyun, K.L. Bok, C.J. Wang, K.L. Nguyen, D. Yoo, E.M. Jung, E. Atti, S. Tetradis, C.R. Pereira, C. Magyar, T. Nargizyan, J.T. Hahn, F. Farouz, S. Thies, and F. Parhami. 2011. Novel oxysterols have pro-osteogenic and anti-adipogenic effects in vitro and induce spinal fusion in vivo. Journal of Cell Biochemistry 112: 1673–1684.CrossRef
Metadata
Title
Alteration of Some Inflammatory Biomarkers by Dietary Oxysterols in Rats
Authors
Ida Soto-Rodríguez
Alfonso Alexander-Aguilera
Antonio Zamudio-Pérez
Mireya Camara-Contreras
Guillermo Hernandez-Diaz
Hugo S. Garcia
Publication date
01-08-2012
Publisher
Springer US
Published in
Inflammation / Issue 4/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9442-9

Other articles of this Issue 4/2012

Inflammation 4/2012 Go to the issue